Detalhe da pesquisa
1.
Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first-line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.
Cancer
; 126(11): 2637-2647, 2020 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32129883
2.
Association of pazopanib-induced toxicities with outcome of patients with advanced soft tissue sarcoma; a retrospective analysis based on the European Organisation for Research and Treatment of Cancer (EORTC) 62043 and 62072 clinical trials.
Acta Oncol
; 58(6): 872-879, 2019 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-30831041
3.
Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.
Lancet Oncol
; 19(3): 323-336, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29433963
4.
Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial.
Breast Cancer Res Treat
; 169(3): 497-505, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29435853
5.
Impact of Concomitant Administration of Gastric Acid-Suppressive Agents and Pazopanib on Outcomes in Soft-Tissue Sarcoma Patients Treated within the EORTC 62043/62072 Trials.
Clin Cancer Res
; 25(5): 1479-1485, 2019 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30765389
6.
The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
Eur J Cancer
; 109: 51-60, 2019 03.
Artigo
Inglês
| MEDLINE | ID: mdl-30690293
7.
Prospective assessment of the predictive value of the BRCA1 gene status in sarcoma patients treated with trabectedin: an updated analysis of the EORTC 62091 trial.
Cancer Med
; 7(5): 1575-1577, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29656586
8.
Factors predictive of locoregional recurrence following neoadjuvant chemotherapy in patients with large operable or locally advanced breast cancer: An analysis of the EORTC 10994/BIG 1-00 study.
Eur J Cancer
; 79: 226-234, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28527420
9.
Correlation between severe infection and breast cancer metastases in the EORTC 10994/BIG 1-00 trial: Investigating innate immunity as a tumour suppressor in breast cancer.
Eur J Cancer
; 72: 95-102, 2017 02.
Artigo
Inglês
| MEDLINE | ID: mdl-28027521